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Abstract. The Kidd blood group antigens, Jka and Jkb, are two of the 
main surface markers which are found on the membrane of red blood 
cells. The determination of whether a donor or a recipient has the 
Jka and/or the Jkb antigens is crucially important to have a successful 
transfusion without the development of adverse incompatibility-related 
reactions. In Malta, routine serological-based tests are applied with 
the purpose of differentiating between homozygous and heterozygous 
states for the Jk antigens respectively. Although these tests are 
highly specific and sensitive, there are particular clinical scenarios 
where haemagglutination assays are not suitable for determining the 
individual’s Kidd blood group status. Additionally, the alternative 
genotyping procedure has never been applied in Malta within the 
context of blood grouping. The current study was therefore carried out 
to determine whether a molecular-based technique such as Polymerase 
Chain Reaction – Restriction Fragment Length Polymorphism analysis 
(PCR-RFLP) is a suitable alternative procedure for distinguishing 
amongst the three different Kidd phenotypes. After extracting 
deoxyribonucleic acid (DNA) from 50 blood samples obtained from 
serologically-tested healthy blood donors who expressed at least one of 
the Kidd antigens, PCR-RFLP analyses were carried out. The results 
of the latter were then compared with those previously obtained with 
haemagglutination and a complete match was observed between the 
two. Therefore, this PCR-RFLP method was confirmed as a suitable 
alternative laboratory technique that can be used to determine 
efficiently the Kidd blood group of both donors and recipients, in an 
accurate manner without subjectivity as encountered in the case of 
haemagglutination. This research further facilitates the introduction of 
molecular-based techniques in molecular blood transfusion.
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1 Introduction
Red blood cells have surface markers on their membrane, known as 
blood group antigens. The three main blood group antigens that are the 
most clinically significant out of the total 600 are the A and B antigens 
of the ABO blood group system and the Rh-D antigen of the Rh blood 
group system. Nonetheless, there are also other blood group antigens 
which are particularly important for a successful transfusion process. 
Two of these are the Jka and Jkb antigens of the Kidd blood group 
system (Daniels & Bromilow, 2010).
The Kidd blood group system (ISBT 009; symbol Jk) was discovered 
in 1951 by Race et al. The antigens of the Kidd blood group system 
are expressed on the Kidd transmembrane glycoprotein, and the 
gene which is responsible for the production of the Jk antigens is the 
SLC14A1 gene, which in old literature was referred to as Jk, HUT11 
(National Center for Biotechnology Information, 2014). The Jk gene is 
located on chromosome 18q11-q12 and has 11 exons spanning a total of 
30kb (Geitvik et al., 1987).
There are three antigens within the Kidd blood group system: Jka, Jkb 
and Jk3. The Jka antigen is found in 77% of Caucasians, 92% of Blacks 
and 73% of Asians. The Jkb antigen is detected in 74% of Caucasians, 
49% of Blacks and 76% of Asians (Dean, 2005). The Jk3 antigen is 
present on all the red blood cells which express the Jka and/or the 
Jkb antigens, thus 99.8% of all the individuals have the Jk3 antigen, 
regardless of their ethnicity. In fact, the Jk3 antigen is only absent in 
1% of Polynesians and Finns who do not express either Jka or Jkb on 
their erythrocytes (Reid & Shine, 2012). Therefore, when it comes to 
determining the phenotype of the person, testing for the presence of 
the Jka and the Jkb antigens is performed.
The Jka and Jkb antigens are the products of the Jk-1 and the Jk-2 
alleles of the SLC14A1 gene respectively. When one examines the coding 
sequences of the mentioned co-dominant alleles, two fundamental 
differences can be detected; the wildtype Jk-1 allele has an Adenine at 
nucleotide 588 on exon 7 and a Guanine at nucleotide 838 on exon 9 
whereas the mutant Jk-2 allele has a Guanine at nucleotide 588 with an 
accompanying Adenine at nucleotide 838 (Wester, 2010).
This Kidd blood group polymorphism was described for the first 
time almost two decades ago (Olivès et al., 1997). The 588A  G single 
nucleotide polymorphism (SNP) is considered to be silent since both 
resulting codons code for Proline (Pro) as amino acid 196 of the final 
gene product (Hong, Gong & Zhour, 2012). Conversely, the 838G  A 
missense SNP causes the change of amino acid 280 from Asparagine 
(Asn) to Aspartic acid (Asp) (Intharanut et al., 2013). Ultimately, 
this Asn280Asp amino acid substitution can be used to differentiate 
between the Jka
 and the Jk
b antigens (Olivès et al., 1997).
Since the Jk-1 and the Jk-2 alleles can be inherited in a co-dominant 
fashion, there are three possible phenotypes: homozygous for the 
Jka antigen Jk (a+b-), homozygous for the Jkb antigen Jk (a-b+) or 
heterozygous for both antigens Jk (a+b+). In addition, there is also the 
null phenotype, depicted as Jk (a-b-), which is only expressed by 1% 
of Polynesians and Finns that lack both Kidd antigens (Irshaid et al., 
2002).
In Malta, the three main Kidd phenotypes are differentiated from 
one another by use of the haemagglutination techniques which are 
carried out at the state general hospital’s Blood Bank. During this 
serological procedure, a red cell suspension is prepared, which is then 
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divided into two aliquots and mixed with two anti-sera containing 
monoclonal IgM anti-Jka and anti-Jkb antibodies. Then, depending on 
the resultant agglutination pattern, one would determine whether the 
individual has a homozygous or heterozygous expression of the Kidd 
blood group antigens. This assay relies on the concept of antigen-
antibody reactions, which typically consist of the Red Cell Sensitisation 
phase and the Agglutination phase, to detect the antigens of interest 
(Overfield, Dawson & Hamer, 2011).
Haemagglutination is considered as the gold standard technique for 
Kidd phenotyping due to its high levels of specificity and sensitivity. 
Other advantages include the simplicity of the technique and its quick 
and rapid process which ranges from 25 minutes to a maximum of 40 
minutes, leading to a fast turnaround time (Reid, 2009). However, like 
all laboratory techniques, serological haemagglutination has its own 
limitations. It is a highly subjective test and there is the possibility of 
having batch-to-batch variations of the anti-sera that are used.
Furthermore, serology-based investigations cannot be applied on 
blood samples obtained from recently transfused patients, massively 
transfused patients who had a severe haemorrhagic event and 
chronically transfused patients who suffer from thalassaemia, sickle 
cell disease or aplastic anaemias where regular blood transfusions 
are considered to be part of the treatment regime (Westhoff, 2006). 
These patients have the donor’s red blood cells in their circulation, 
which would directly interfere with the test since haemagglutination 
techniques are incapable of differentiating between the patient’s and 
the donor’s red blood cells (Castilho & Pellegrino, 2004).
Moreover, individuals who suffer from some form of autoimmune 
haemolytic anaemias (AIHA) such as Cold Agglutinin Disease, Warm 
AIHA, Paroxysmal Cold Haemoglobinuria and Drug-Induced AIHA, 
cannot be typed by haemagglutination. These patients have circulating 
auto-antibodies which coat their red cells and cause spontaneous 
agglutination. Consequently, false positive reactions can be observed 
with haemagglutination-based tests since the observed agglutination 
would not have occurred due to a reaction between the red blood cells 
and the anti-sera reagents but due to the reaction that transpired 
between the erythrocytes and the individual’s own auto-antibodies 
(Westhoff, 2006).
Thus, a number of conditions can result in a higher risk of Kidd 
blood group status mistyping. This may lead to transfusion with 
incompatible red cells, therefore increasing the risk of haemolytic 
transfusion reactions (HTR) (Overfield, Dawson & Hamer, 2011). In 
order to overcome these limitations, genotyping procedures are being 
introduced to complement the routine serological techniques.
In Malta, the antigens of the Kidd blood group system have never 
been genotyped by molecular techniques, due to the fact that they 
are phenotyped on a routine basis with serological tests. The purpose 
of this study was therefore to validate Polymerase Chain Reaction – 
Restriction Fragment Length Polymorphism (PCR-RFLP) analysis, a 
molecular-based procedure which is specific, sensitive and capable of 
differentiating between the Jka and Jkb antigens and their respective 
genotypes in a non-subjective manner.
2 Methods
2.1 Selection of samples
Fifty volunteer, regular, healthy Maltese blood donors from Malta’s 
national blood transfusion centre were recruited for this study. These 
blood donors were chosen on the premise that they had already been 
tested by haemagglutination during past donations and thus, their 
phenotype for the Kidd blood group antigens was known. Donors were 
selected in such a way as to have the three different Kidd phenotypes 
represented in the study. Other selection criteria, such as age and 
gender, were not considered. Once each chosen donor voluntarily 
underwent the donation process, 9 mL of blood were transferred from 
the blood donation bag’s sample diversion pouch into a 10 mL purple-
capped vacutainer containing ethylenediaminetetraacetic acid (EDTA) 
anticoagulant. Approval for the collection of blood samples was 
obtained from the University of Malta’s Research Ethics Committee.
2.2 Deoxyribonucleic acid (DNA) extraction
The salting out technique (Miller, Dykes & Polesky, 1988) was 
implemented to extract the deoxyribonucleic acid (DNA) from the 50 
whole blood samples. The extracted DNA was dissolved in sterile Tris 
EDTA buffer (TE) and quantified using the Nanodrop 2000c UV-VIS 
Spectrophotometer. The samples were diluted to a concentration of 50 
ng/µL in a total volume of 20 µL using TE buffer. In addition, a random 
batch of DNA samples was analysed by 1% agarose gel electrophoresis 
to re-confirm the quality of the extracted DNA.
2.3 Polymerase Chain Reaction (PCR)
The JK1S forward primer [5’-TGAGATCTTGGCTTCCTAGG-3’] and the 
JK2 reverse primer [5’-ATTGCAATGCAGGCCAGAGA-3’] were the two 
published primer sequences which were used to target the Kidd blood 
group system gene (Denomme, Rios & Reid, 2000).
The Master Mix that was prepared during the optimised PCR runs 
is shown in Table 1, whereas Table 2 shows the thermal cycler’s profile 
which was used to carry out the amplification of the Kidd gene. The 
resultant PCR products were qualitatively checked with 2% agarose gel 
electrophoresis.
Table 1. PCR components and Master Mix volumes
PCR components Amount per reaction Master Mix volumes
2x ReddyMix Master Mix 5 µL 280 µL
JK1S forward primer (50 µM) 0.1 µL 5.6 µL
JK2 reverse primer (50 µM) 0.1 µL 5.6 µL
Genomic DNA (50 ng/µL) 1 µL /
Sterile Water 3.8 µL 212.8 µL
Final Volume 10 µL 504 µL
Table 2. PCR Mastercycler® profile for the amplification of the Kidd  
blood group gene
Number of cycles PCR step Temperature Time
1 cycle Initial hot start 95°C 5 minutes
28 cycles Denaturation 95°C 50 seconds
Annealing 56°C 30 seconds
Extension 72°C 45 seconds
1 cycle Final extension 72°C 10 minutes
1 cycle Incubation period 4°C ∞
2.4 Restriction enzyme digestion
Based on the same published work from which the primers’ sequences 
were obtained, MnlI was the restriction enzyme that was chosen to carry 
out digestion of the PCR products (Denomme, Rios & Reid, 2000). A 
Master Mix was prepared accordingly, as shown in Table 3, and the 
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PCR products were digested overnight with MnlI enzyme (New England 
Biolabs, Hertfordshire, United Kingdom).
The expected fragment sizes for each genotype were obtained via 
online analysis with the NEB cutter website (http://nc2.neb.com/
NEBcutter2/) and are shown in Table 4 and in Figure 1.
Table 3. Restriction enzyme digestion reaction and Master Mix volumes
Digest component Amount per reaction Master Mix
NEBuffer 4 2 µL 112 µL
MnlI Enzyme (5,000 U/mL) 0.9 µL 50.4 µL
Sterile water 12.1 µL 677.6 µL
PCR products 5 µL /
Table 4. The expected sizes of the DNA fragments (in base pairs) of the 
three Kidd blood group genotypes
Homozygous Jka/Jka Homozygous Jkb/Jkb Heterozygous Jka/Jkb
- 84 84
78 78 78
62 - 62
48 48 48
22 - 22
Figure 1. Kidd blood group gene restriction maps; the top image shows a graphical representation of the four DNA fragments 
obtained from the Jka-encoding Jk-1 wildtype allele following digestion by the restriction enzyme MnlI. In this case, the enzyme 
recognised three 5’ - CCTC (N)7  - 3’ recognition sites. The bottom image shows a graphical representation of the three DNA 
fragments obtained from the Jkb-encoding Jk-2 mutant allele which had two recognition sites, with one of the original three 
recognition sites being abolished due to the 838G  A missense SNP.
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Figure 2. Restriction enzyme digest result; gel image of the MnlI-digested Kidd blood group gene when run on 3% Micro ABgarose gel 
electrophoresis. Lanes 4 and 7 show the homozygous Jka genotype, lanes 8 and 9 show the homozygous Jkb genotype and lanes 5, 6, 
and 10 show the heterozygous Jka/b genotype.
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2.5 Final Micro ABgarose gel electrophoresis
The digested PCR products were separated via 3% Micro ABgarose gel 
electrophoresis and analysed with a UV-transilluminator Bio-Doc-It® 
Imaging System.
3 Results
On direct comparison, all PCR-RFLP results matched completely with 
the haemagglutination results, as shown in Table 5.
Table 5. Haemagglutination results compared with PCR-RFLP results
Number of samples Haemagglutination PCR-RFLP Match percentage
11 Jka + / Jkb - Jka 100%
14 Jka - / Jkb + Jkb 100%
25 Jka + / Jkb + Jka/b 100%
Additionally, Figure 2 shows the digested PCR fragments and the 
three Kidd blood group genotypes.
4 Discussion and Conclusion
This study confirmed that the three different Kidd blood group 
genotypes, homozygous Jka, homozygous Jkb and heterozygous Jka/b, 
can be successfully differentiated from one another by PCR-RFLP. 
This validated PCR-RFLP technique can therefore be applied to 
blood samples obtained from recently transfused patients, massively 
transfused patients, chronically transfused patients and individuals 
who have AIHA, ensuring that these persons who cannot be tested 
by serology, due to potential interferences from either the donor’s 
transfused red blood cells or their own auto-antibodies respectively, 
can have their Kidd blood group status genotyped correctly.
Furthermore, given that this study was the first successful 
undertaking within the field of molecular transfusion, further research 
is warranted to determine whether this genotyping technique can be 
used to differentiate the genotypes of other clinically significant blood 
groups. This is especially relevant in view of the fact that molecular 
genotyping of the other blood group antigens such as the A, B and O 
antigens of the ABO blood group system, the C, c, D, E and e antigens 
of the Rh blood group system, the Fya and Fyb antigens of the Duffy 
blood group system, the K antigen of the Kell blood group system and 
the M, N, S and s antigens of the MNS blood group system, amongst 
others, has never been carried out in Malta.
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